CXCL8 and chronic obstructive pulmonary disease: In future, it is very important to investigate whether DEX inhibits OGR1-mediated CXCL8 secretion in ASMCs isolated from patients with steroid-resistant asthma or COPD, because ASMCs of patients with severe asthma seem to be insensitive to corticosteroids [62, 63].